| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000258959.1 |
AKT inhibitor VIII |
Bladder urothelial carcinoma |
0.01221453 |
Resistant |
| ENSG00000258959.1 |
AKT inhibitor VIII |
Liver hepatocellular carcinoma |
0.034536869 |
Resistant |
| ENSG00000258959.1 |
AKT inhibitor VIII |
Pancreatic adenocarcinoma |
0.034828979 |
Resistant |
